Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients
- 28 October 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (3), 412-417
- https://doi.org/10.1002/ijc.11596
Abstract
Conventional histopathologic staging of primary colorectal cancers does not allow accurate prognostic stratification within a given tumour stage. Therefore, PCR‐based assays are increasingly used to try to predict more accurately the likelihood of disease progression for the individual patient. Real‐time reverse transcription PCR (RT‐PCR) assays were used to detect and quantitate cytokeratin 20 (ck20), carcinoembryonic antigen (CEA) and guanylyl cyclase C (GCC) mRNA in 149 lymph nodes (LN) from 17 patients with benign disease and 302 LN from 42 patients with colorectal cancer who had curative (R0) resections. None of the markers were specific, with ck20, CEA and GCC mRNA detected in 47%, 89% and 13% of 149 LN, respectively, from patients with benign disease. The sensitivity of all 3 markers was very high, with mRNA detected in 93%, 100% and 97% of 30 histologically involved LN, respectively. There was significant overlap in the mRNA levels of all 3 markers between histologically involved and uninvolved LN. There was no association between mRNA levels and distant recurrence (median follow‐up: 3.94 years, range 3.35–5.12). We conclude that the use of molecular techniques to detect occult disease in LN may suffer from the same limitations as conventional methods. Instead, accurate prognostic stratification requires careful assessment of the likely metastatic potential of the primary cancer.Keywords
This publication has 26 references indexed in Scilit:
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cellsOncogene, 2002
- Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problemsJournal of Molecular Endocrinology, 2002
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Molecular assessment of tumour stage and disease recurrence using PCR-based assaysMolecular Medicine Today, 1998
- Prognostic factors in colorectal cancerDiseases of the Colon & Rectum, 1998
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20International Journal of Cancer, 1998
- Genetic diagnosis of lymph-node metastasis in colorectal cancerThe Lancet, 1995
- The Cellular Basis of Site-Specific Tumor MetastasisNew England Journal of Medicine, 1990